A company called Rapid Fire Marketing says that its subsidiary Medical Cannabis Management is launching a tetrahydrocannabinol (THC) e-cigarette in the US immediately and will follow with a second-generation device in 30-60 days. The device, called the CannaCig, is designed to deliver THC “in an oil form,” according to the company, and will be sold through physicians and cannabis dispensaries. The company claims that the THC formulation “provides the same medical effects as the natural cannabis plant.”
The company provided a link to photos of both devices.
MCM CEO Mike Amezquita commented, “We have been working very hard over the last couple of months to get this product into the marketplace as quickly as possible. We want to get California covered and then embark on a national campaign to get the CannaCig into medical cannabis dispensaries and to physicians in other states.”
In December, 2010, the US Court of Appeals ruled that the FDA has no jurisdiction to regulate e-cigarettes as drug-device combinations; however, the ruling defined e-cigarettes as “battery-powered products that allow users to inhale nicotine vapor” and specifed that the products were making no therapeutic claims.
Read the Rapid Fire Marketing press release.
